title: Finally, Attention Switches To Progressive Multiple Sclerosis.
abstract: The surge of new MS treatments have been for the relapsing-remitting form of the disease. There's hope for sufferers of a different form of MS. By homing in on CD20-positive B cells, ocrelizumab is able to knock them out and other aberrant B cells circulating in the bloodstream.
authors.forename: Thomas
authors.initials: T
authors.lastname: Reinke
mesh_terms: D001402:B-Lymphocytes; D006801:Humans; D009103:Multiple Sclerosis; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000628:therapy*